Sesen Bio's Series B Round

Sesen Bio raised a round of funding on December 02, 2013.

Sesen Bio, formerly Eleven Biotherapeutics, is a late-stage company developing next-generation antibody-drug conjugate (ADC) therapies for patients with cancer.…

Articles about Sesen Bio's Series B Round: